China Clears HIV Oral Antiviral For COVID, Vows More Drug Approvals

As the Communist Party of China gears up for its once in every five years National Congress late this fall, the need for more novel drugs to help address the persistent coronavirus pandemic is rising amid the country’s strict “COVID Zero” policies.

Doctor with Covid pill
CHINA APPROVES AZVUDINE FOR COVID-19, VOWS MORE DRUG NODS • Source: Shutterstock

China has granted the first approval for a domestically-originated oral antiviral drug for COVID-19, as the country faces rising economic pressures as cases and infections continue to flare up around the nation.

Azvudine, a novel nucleoside reverse transcriptase inhibitor originally developed by little-known Henan Genuine Biotech for HIV, was granted an emergency use authorization in the new setting on 25 July

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from China

More from Asia